AMICUS THERAPEUTICS, INC. Foreign Pre-Tax Income
AMICUS THERAPEUTICS, INC. reported Foreign Pre-Tax Income of $123.37 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign · last filed 2026-02-20
- AMICUS THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, foreign for fiscal 2025 was $123.37M, a 31.95% decline from fiscal 2024.
- AMICUS THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, foreign for fiscal 2024 was $181.29M, a 114.85% increase from fiscal 2023.
- AMICUS THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, foreign for fiscal 2023 was $84.38M, a 16.77% decline from fiscal 2022.
- AMICUS THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, foreign for fiscal 2022 was $101.39M, a 10.18% increase from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Foreign 12 month |
|---|---|
| 2025-12-31 | $123.37M 10-K · filed 2026-02-20 |
| 2024-12-31 | $181.29M 10-K · filed 2026-02-20 |
| 2023-12-31 | $84.38M 10-K · filed 2026-02-20 |
| 2022-12-31 | $101.39M 10-K · filed 2025-02-19 |
| 2021-12-31 | $92.02M 10-K · filed 2024-02-28 |
| 2020-12-31 | $91.08M 10-K · filed 2023-03-01 |
| 2019-12-31 | $38.05M 10-K · filed 2022-02-24 |
| 2018-12-31 | -$39.91M 10-K · filed 2021-03-01 |
| 2017-12-31 | -$8.43M 10-K · filed 2020-03-02 |
| 2016-12-31 | -$28.87M 10-K · filed 2019-02-28 |
| 2015-12-31 | -$8.42M 10-K · filed 2018-03-01 |
| 2014-12-31 | -$9.00K 10-K/A · filed 2017-03-03 |
| 2013-12-31 | -$9.00K 10-K · filed 2016-02-29 |